C-5FX4Fate Therapeutics
iPSC platform, cell programming, cellular immunotherapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
C-5FX4iPSC platform, cell programming, cellular immunotherapy
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Fate Therapeutics presents a belief that medicine can be transformed by controlling the destiny of adult cells: specifically by awakening adult stem cells already resident in the body to fight disease and regenerate damaged cells and tissue, and by using small molecules to reprogram mature adult cells into an embryonic-like pluripotent state. The company frames these approaches as broadly applicable to degenerative diseases, developmental disorders, cancer, and the creation of patient-identical cells for transplantation, while emphasizing adult-cell-based science over embryo-derived stem cells.
SourceFate Therapeutics states that advances in adult stem cell biology can be translated into medicines that direct cell fate, awaken stem cells already present in the body to repair damage and fight disease, and use small molecules to reprogram mature adult cells into an embryonic-like pluripotent state, offering a new path for treating degenerative disease, traumatic injury, cancer, and for creating iPSCs for research and drug development without relying on embryo-derived stem cells.
SourceFate Therapeutics presents the belief that a fundamentally new era in medicine is possible through controlling the destiny of adult cells. It states that adult stem cells already resident in the body can be awakened to fight disease and regenerate damaged cells and tissue, and that small molecules can reprogram mature adult cells to an embryonic-like state. The company frames these approaches as broadly applicable to degenerative disease, developmental disorders, cancer, and the creation of patient-identical cells for transplantation, while emphasizing alternatives to embryo-derived stem cells.
SourceFate Therapeutics presented itself as a regenerative medicine company built on the belief that cell fate can be understood and deliberately controlled, and that drugs acting on stem cells and their developmental pathways could direct repair, regeneration, or replacement of damaged tissues. Its stated stance was that modulating stem cells and related biological signals could produce therapeutics for serious diseases, rather than relying only on transplanted cells or symptomatic treatment.
Source